ArticleOncoimmunology

Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial.

Poulam M Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.